Landaas & Company’s Pfizer PFE Stock Holding History

Landaas & Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,786	Closed	-$225K	–	82
2023 Q3	$225K	Buy	6,786 +27	+0.4%	+$955	0.1%	66
2023 Q2	$248K	Hold	6,759	–	–	0.11%	61
2023 Q1	$276K	Hold	6,759	–	–	0.13%	50
2022 Q4	$346K	Hold	6,759	–	–	0.19%	37
2022 Q3	$296K	Hold	6,759	–	–	0.19%	41
2022 Q2	$354K	Hold	6,759	–	–	0.22%	40
2022 Q1	$399K	Hold	6,759	–	–	0.21%	42
2021 Q4	$399K	Hold	6,759	–	–	0.21%	42
2021 Q3	$291K	Sell	6,759 -370	-5%	-$16.4K	0.17%	49
2021 Q2	$279K	Hold	7,129	–	–	0.16%	52
2021 Q1	$258K	Hold	7,129	–	–	0.15%	58
2020 Q4	$262K	Sell	7,129 -314	-4%	-$11.5K	0.18%	48
2020 Q3	$259K	Sell	7,443 -506	-6%	-$17.7K	0.2%	46
2020 Q2	$247K	Hold	7,949	–	–	0.2%	46
2020 Q1	$275K	Sell	7,949 -137	-2%	-$4.67K	0.23%	44
2019 Q4	$301K	Sell	8,086 -211	-3%	-$7.52K	0.21%	46
2019 Q3	$283K	Hold	8,297	–	–	0.21%	44
2019 Q2	$341K	Sell	8,297 -1,163	-12%	-$46.2K	0.24%	39
2019 Q1	$381K	Sell	9,460 -273	-3%	-$10.9K	0.28%	35
2018 Q4	$403K	Buy	9,733 +2	+0%	+$83	0.33%	32
2018 Q3	$407K	Buy	9,731 +2	+0%	+$77	0.32%	35
2018 Q2	$335K	Buy	9,729 +530	+6%	+$18.1K	0.27%	38
2018 Q1	$310K	Sell	9,199 -37	-0.4%	-$1.27K	0.31%	36
2017 Q4	$317K	Buy	9,236 +2	+0%	+$68	0.27%	37
2017 Q3	$313K	Buy	+9,234	New	+$297K	0.28%	42

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Landaas & Company's PFE Position: Q4 2023 in Review

Landaas & Company sold out of Pfizer (PFE) in Q4 2023, closing a stake of 6,786 shares — an estimated $225K sold.

Landaas & Company first reported a position in PFE in Q3 2017 and held it in 25 quarters. The position peaked at $407K in Q3 2018. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Landaas & Company reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Landaas & Company sold 6,786 Pfizer shares in Q4 2023, an estimated $225K.
Landaas & Company first reported a position in Pfizer in Q3 2017 and held it in 25 quarters.
Landaas & Company's Pfizer position peaked at $407K in Q3 2018.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Landaas & Company's 13F filing for Q4 2023, filed 12 Feb 2024.